PharmaCyte Biotech (PMCB) Current Assets (2011 - 2026)
PharmaCyte Biotech's Current Assets was $30.97 million in fiscal Q1 2027 (quarter ended Jul 31, 2026), up 62.1% from $19.11 million a year earlier but down 17.2% from the prior quarter.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Current Assets (2011 - 2026) Analysis & Trends
At the end of FY2026 (ended Apr 30, 2026), Current Assets at PharmaCyte Biotech came in at $37.42 million, up 67.2% from FY2025.
- Current Assets shows a five-year compound annual growth rate of 75.1% (FY2021 to FY2026).
- In earlier fiscal years, Current Assets was $22.38 million in FY2025 (-55.6%), $50.44 million in FY2024 (-26.0%), $68.15 million in FY2023 (-20.3%) and $85.49 million in FY2022.
- Quarterly Current Assets has moved between $16.96 million (fiscal Q3 2025) and $87.18 million (fiscal Q2 2022) over five years.
- Compared with a year earlier, Current Assets has increased for four straight quarters, with an average decline of 10.2% over the last eight quarters.
- The best year-over-year quarter for Current Assets over five years was fiscal Q4 2026 (growth of 67.2%); the worst was fiscal Q3 2025 (a decline of 72.4%).
- Per Business Quant data, PMCB's Current Assets in the three fiscal quarters before Q1 2027 was $37.42 million (Q4 2026), $20.7 million (Q3 2026) and $23.02 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 12.54 Bn |
| 10 | PharmaCyte Biotech | 4.40 Mn | 4.40 Mn | - | 30.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 30.97 Mn |
| Apr 30, 2026 | 37.42 Mn |
| Jan 31, 2026 | 20.70 Mn |
| Oct 31, 2025 | 23.02 Mn |
| Jul 31, 2025 | 19.11 Mn |
| Apr 30, 2025 | 22.38 Mn |
| Jan 31, 2025 | 16.96 Mn |
| Oct 31, 2024 | 21.33 Mn |
| Jul 31, 2024 | 32.88 Mn |
| Apr 30, 2024 | 50.44 Mn |
| Jan 31, 2024 | 61.51 Mn |
| Oct 31, 2023 | 73.75 Mn |
| Jul 31, 2023 | 74.75 Mn |
| Apr 30, 2023 | 68.15 Mn |
| Jan 31, 2023 | 72.82 Mn |
| Oct 31, 2022 | 77.22 Mn |
| Jul 31, 2022 | 82.26 Mn |
| Apr 30, 2022 | 85.49 Mn |
| Jan 31, 2022 | 86.81 Mn |
| Oct 31, 2021 | 87.18 Mn |
API Access
PharmaCyte Biotech Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();